Latest Lung Cancer Treatments Improve the Survival Rate

Lung cancer is one of the most prevalent forms of cancer that exists. It usually transpires with smokers, but there are also instances of non-smokers having it. This may arise due to passive smoking, air pollution, or regular inhaling of diesel exhaust at the workplace. Lung cancers detected in non-smokers usually occur within people of a younger demographic profile and often have variations in the mutated genes compared to smokers with lung cancer. At times, we can also acquire these mutated genes that enhance the risk of having lung cancer. However, these inherited mutations alone aren’t always the reason.

Lung cancer treatments are always emerging and advancing. In the past two years, fresh prospects on approaching cancer therapy led to interesting explorations for research therapies. Today’s cancer therapies are further targeted and competent in reconstructing lung cancer progression while also conserving the quality of life. In prevailing years, many curative options have developed for treating stage 4, or metastatic, lung cancer, significantly improving survival rates. 

Recent researches assert that more than 80% of all lung cancers are the non-small cell type. Lung cancers usually affect men more than women, which is not strange because more men smoke than women. However, many people don’t know that lung cancer is the leading cause of cancer deaths in women, even though only 20% smoke.

Although lung cancer is so prevalent, there is not much information available to us about it. Most of the data present is procured from people who are already administered with it. Due to this, many events are hosted to spread awareness, like World Cancer Day, observed on the 4th of February. Aloof from this, many lung cancer doctors offer advice and administration to those people amongst us who are diagnosed with lung cancer.

As per the latest Lung cancer treatment statistics in India,  one out of every 68 males in India suffers from lung cancer. However, lung cancer patients’ survival has progressed in India from 11 months to a 5-year survival rate of 17.8% over the last decade, which is more than anticipated. According to the best lung cancer doctor in Delhi NCR, this has been possible due to the availability of exceptional chemotherapy, radiation therapy, and targeted therapy drugs to a large extent. 

With more than 68,000 lung cancer cases in India, as per a WHO report, when it comes to lung cancer, survival rates differ in different stages of lung cancer. However, stage 3 lung cancer is still treatable. The lung cancer treatment progress in India showshow research & development towards using CAR-T cells therapy, immunotherapies, and molecularly targeted therapies signifies an assuring future of India’s cancer treatment. Medical practitioners consider that these treatments can extend patients’ quality of life and help those suffering from Stage 3 lung cancer.

Research exhibits that stage three lung cancer’s life expectancy rate ranges from 13% to 33%. According to our cancer specialist in Delhi, Stage 3 lung cancer treatment generally begins with surgery to remove the cysts in the lungs. Although in stage 3A, there can be more than one tumour in the lungs, the therapy includes chemotherapy and radiation post-surgery. 

In Stage 3B, along with tumours, cancer may spread to lymph nodes even on the reverse side of the patient’s chest, and the patient can require the compound of both chemo and radiation for their lung cancer treatment. Additionally, in stage 3C, patients can hold multiple tumours in the lungs, and the cancer cells can reach the breastbone, chest walls, and heart. 

At this stage, our cancer doctor may suggest both chemotherapy or radiation treatment if an operation is not feasible to eliminate the tumour. Along with researchers’ lung cancer treatment update,  that explicates an improvement in the use of medication options like immunotherapy. Reports reveal that stage 3 of lung cancer has prominent symptoms, like a persistent cough, difficulty breathing, discomfort in the chest area, weight loss, headache, etc. Hence, It is essential to consult with a cancer specialist at this point. Besides, studies reveal that just one-third of patients reach stage 3 after being diagnosed with metastatic lung cancer.

Lung cancer in India holds a 9.3% death rate that has led to the institution and development of many institutes and amenities to counter it. Dr Manish Kumar Singhal is regarded as a distinguished oncologist currently practising at Cancer Consult India. He is also the Head of the Medical Oncology Department & Senior Consultant Medical Oncology Apollo Hospital. He has a remarkably motivated team of cancer specialists in Delhi, as well as top-notch treatment facilities. Due to his allegiance and expertise, Dr Manish Singhal is considered the best lung cancer doctor in Delhi, NCR.